Rasagiline is a recently approved monoamine oxidase B inhibitor used in PD that is often prescribed in the early stages of treatment. Based on evidence found in laboratory models, a recent trial ...

In an analysis of health data from 130million people, British researchers found medications which could potentially increase, or decrease, the risk that someone could be diagnosed with dementia.

a MAO-B = monoamine oxidase type B, MAO-A = monoamine oxidase type A. b Expressed as the molar concentration of drug required to inhibit enzyme activity by 50% (nmol/L). c Expressed as the ...